Enemeez® Product Usage

Therapeutic Patient Profile:

Enemeez® is effective for bowel care needs associated with spinal cord injury and disease, multiple sclerosis, traumatic brain injury, spina bifida, stroke and constipation. Adults and children 12 years of age and older (with adult supervision), one to three units daily. Children under 6 years of age, consult a physician prior to use.

Pediatric administration: Enemeez® should not be used in pediatrics without prior instruction from a medical professional. Consult your physician prior to using Enemeez® to receive thorough instruction on pediatric administration techniques.





Therapeutic Use:


This product is employed for the relief of constipation due to infrequent or difficult bowel movements. Enemeez® and Enemeez® Plus penetrates and softens the stool, thereby promoting bowel movement. It is indicated for dyschezia, lesions of the anus that make defecation painful, impaction associated with megacolon, anal fissure, and postoperative anal atresia. It has been employed successfully in bedridden patients and those patients with decreased mobility in a patient group from child to adult. Enemeez® and Enemeez® Plus neurogenic bowel management programs in acute rehabilitation patients with such diagnoses as spinal cord injuries, cerebral vascular accidents, fractures, stroke, multiple sclerosis, spina bifida, joint replacements, and closed head injuries. Enemeez® provides faster and more predictable bowel routine along with reducing bowel accidents and incontinence. Enemeez® Plus also contains Benzocaine to anesthetize the rectum and lower bowel; and is beneficial when an anesthetic is needed to prevent hyperreflexia crisis or painful bowel movement.

Clinical Pharmacokinetics:

The Enemeez® formulation functions as a hyperosmotic laxative by drawing water into the bowel from surrounding body tissues. The docusate sodium acts as a softener by preparing the stool to readily mix with watery fluids. The increased mass of stool promotes a bowel evacuation by stimulating nerve endings in the bowel lining and initiating peristalsis. Not only does it soften and loosen the stool but it initiates a normal stimulus. Enemeez® provides the most natural replicated bowel movement of all bowel care products on the market today.

Administration and Dosing:

Enemeez® is to be used as an enema. This is not a suppository. Do not take orally.

Administering the mini-enema:

Clear any stool from the rectal opening (as you do not want to insert directly into feces) and apply lubrication to be applied to anus. With steady pressure, gently insert the tube into the rectum. Squeeze to empty the contents. After the contents have been emptied, remove the disposable tube and discard.

Dosage:

Enemeez®, if you have no BM in 30 minutes Enemeez® x1, x2 or x3. Use one to three units rectally as needed or as directed by a physician. This process can be administered safely up to 3 times during a bowel care session or per day. Do not exceed physician's recommendations.

Time to Peak:

Most patients will have a stimulus within 2-5 minutes. Elimination will typically take place within 2-15 minutes. After evacuation, perform digital stimulation to ensure the program is complete.

Patients with severe constipation:

If no evacuation occurs after the 15 minute period, perform digital stimulation to assist in bringing the stool down.

Caution:

Discontinue use if resistance is encountered during insertion. Forcing the tube may result in injury or damage to the rectum. If product is not administered properly and occasional rectal examinations are not performed, serious complications may arise. Occasional rectal exams are imperative for patients with impaired rectal function, especially loss of sensation. Allergies and Interactions: Individuals with sensitivity to Benzocaine should not use Enemeez® Plus. If rectal irritation or a rash around the anus appears, the enemas should be discontinued. Prolonged administration together with mineral oil should be avoided.

Warnings:

Do not use laxative products when abdominal pain, nausea or vomiting are present for a period longer than 1 week unless directed by a physician. If you have noticed a sudden change in bowel habits that persists over a period of 2 weeks, consult a physician before using a laxative. Rectal bleeding or failure to have a bowel movement after use of a laxative may indicate a serious condition. Discontinue use and consult your physician.